Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Fixed-dose Combination of Bromopride and Simethicone Versus Isolated Bromopride in Participants With Functional Dyspepsia.

NCT02604576 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT02604576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02604576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Fixed-dose Combination of Bromopride and Simethicone Versus Isolated Bromopride in Participants With Functional Dyspepsia.
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
January 17, 2017
Completion date
March 11, 2019
Enrollment
339 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dyspepsia